17-45136518-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001378112.1(ACBD4):c.-199A>G variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000217 in 1,613,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
ACBD4
NM_001378112.1 5_prime_UTR_premature_start_codon_gain
NM_001378112.1 5_prime_UTR_premature_start_codon_gain
Scores
3
7
9
Clinical Significance
Conservation
PhyloP100: 6.48
Genes affected
ACBD4 (HGNC:23337): (acyl-CoA binding domain containing 4) This gene encodes a member of the acyl-coenzyme A binding domain containing protein family. All family members contain the conserved acyl-Coenzyme A binding domain, which binds acyl-CoA thiol esters. They are thought to play roles in acyl-CoA dependent lipid metabolism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.4010666).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACBD4 | NM_001135705.3 | c.107A>G | p.Tyr36Cys | missense_variant | 3/10 | ENST00000321854.13 | NP_001129177.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACBD4 | ENST00000321854.13 | c.107A>G | p.Tyr36Cys | missense_variant | 3/10 | 1 | NM_001135705.3 | ENSP00000314440.8 | ||
ACBD4 | ENST00000591859.5 | c.107A>G | p.Tyr36Cys | missense_variant | 5/12 | 1 | ENSP00000465610.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151924Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
151924
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249030Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135144
GnomAD3 exomes
AF:
AC:
6
AN:
249030
Hom.:
AF XY:
AC XY:
1
AN XY:
135144
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461282Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 726970
GnomAD4 exome
AF:
AC:
30
AN:
1461282
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
726970
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151924Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74198
GnomAD4 genome
AF:
AC:
5
AN:
151924
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74198
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.107A>G (p.Y36C) alteration is located in exon 5 (coding exon 2) of the ACBD4 gene. This alteration results from a A to G substitution at nucleotide position 107, causing the tyrosine (Y) at amino acid position 36 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;T;T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;.;.;D;.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;M;M;.;M;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;.;.;D;.;D;D
REVEL
Benign
Sift
Uncertain
.;D;.;.;D;.;T;D
Sift4G
Benign
T;T;T;T;D;T;T;D
Polyphen
D;D;D;D;D;.;D;D
Vest4
MutPred
Loss of phosphorylation at Y36 (P = 0.0367);Loss of phosphorylation at Y36 (P = 0.0367);Loss of phosphorylation at Y36 (P = 0.0367);Loss of phosphorylation at Y36 (P = 0.0367);Loss of phosphorylation at Y36 (P = 0.0367);Loss of phosphorylation at Y36 (P = 0.0367);Loss of phosphorylation at Y36 (P = 0.0367);Loss of phosphorylation at Y36 (P = 0.0367);
MVP
MPC
0.77
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at